x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission File Number: 0-24249 | ||
PDI, Inc. | ||
(Exact name of registrant as specified in its charter) | ||
Delaware | 22-2919486 | |
(State or other jurisdiction of Incorporation or organization) | (I.R.S. Employer Identification No.) | |
Morris Corporate Center 1, Building A | ||
300 Interpace Parkway, Parsippany, NJ 07054 | ||
(Address of principal executive offices and zip code) | ||
(800) 242-7494 | ||
(Registrant's telephone number, including area code) |
Large accelerated filer o | Accelerated filer o | Non-accelerated filer o | Smaller reporting company x |
(Do not check if a smaller reporting company) |
Class | Shares Outstanding August 1, 2013 | |
Common stock, $0.01 par value | 15,190,760 | |
Page No. | |||
PART I - FINANCIAL INFORMATION | |||
Item 1. | |||
Item 2. | |||
Item 3. | |||
Item 4. | |||
PART II - OTHER INFORMATION | |||
Item 1. | |||
Item 1A. | |||
Item 5. | Other Information | ||
Item 6. | |||
June 30, 2013 | December 31, 2012 | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 51,023 | $ | 52,783 | |||
Short-term investments | 92 | 92 | |||||
Accounts receivable, net | 6,103 | 10,687 | |||||
Unbilled costs and accrued profits on contracts in progress | 7,554 | 1,955 | |||||
Other current assets | 6,025 | 6,066 | |||||
Total current assets | 70,797 | 71,583 | |||||
Property and equipment, net | 2,775 | 2,396 | |||||
Goodwill | 2,523 | 2,523 | |||||
Other long-term assets | 1,182 | 1,945 | |||||
Total assets | $ | 77,277 | $ | 78,447 | |||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 3,147 | $ | 3,388 | |||
Unearned contract revenue | 11,969 | 14,501 | |||||
Accrued salary and bonus | 8,577 | 6,674 | |||||
Other accrued expenses | 10,090 | 11,827 | |||||
Total current liabilities | 33,783 | 36,390 | |||||
Long-term liabilities | 5,779 | 6,427 | |||||
Total liabilities | 39,562 | 42,817 | |||||
Commitments and contingencies (Note 7) | |||||||
Stockholders’ equity: | |||||||
Preferred stock, $.01 par value; 5,000,000 shares authorized, no shares issued and outstanding | — | — | |||||
Common stock, $.01 par value; 40,000,000 shares authorized | |||||||
16,319,554 and 16,063,514 shares issued, respectively; | |||||||
15,190,760 and 14,965,875 shares outstanding, respectively | 163 | 161 | |||||
Additional paid-in capital | 129,579 | 128,508 | |||||
Accumulated deficit | (78,016 | ) | (79,258 | ) | |||
Accumulated other comprehensive income | 11 | 11 | |||||
Treasury stock, at cost (1,128,794 and 1,097,639 shares, respectively) | (14,022 | ) | (13,792 | ) | |||
Total stockholders' equity | 37,715 | 35,630 | |||||
Total liabilities and stockholders' equity | $ | 77,277 | $ | 78,447 |
Three Months Ended | Six Months Ended | ||||||||||||||
June 30, | June 30, | ||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||
Revenue, net | $ | 37,245 | $ | 27,809 | $ | 80,168 | $ | 59,486 | |||||||
Cost of services | 30,396 | 21,239 | 64,846 | 45,550 | |||||||||||
Gross profit | 6,849 | 6,570 | 15,322 | 13,936 | |||||||||||
Compensation expense | 4,914 | 4,069 | 9,069 | 8,651 | |||||||||||
Other selling, general and administrative expenses | 2,782 | 2,817 | 4,847 | 5,822 | |||||||||||
Total operating expenses | 7,696 | 6,886 | 13,916 | 14,473 | |||||||||||
Operating (loss) income | (847 | ) | (316 | ) | 1,406 | (537 | ) | ||||||||
Other expense, net | (24 | ) | (15 | ) | (34 | ) | (15 | ) | |||||||
(Loss) income from continuing operations before income tax | (871 | ) | (331 | ) | 1,372 | (552 | ) | ||||||||
Provision for income tax | 64 | 63 | 128 | 145 | |||||||||||
(Loss) income from continuing operations | (935 | ) | (394 | ) | 1,244 | (697 | ) | ||||||||
Income (loss) from discontinued operations, net of tax | 52 | (45 | ) | (2 | ) | (14 | ) | ||||||||
Net (loss) income | $ | (883 | ) | $ | (439 | ) | $ | 1,242 | $ | (711 | ) | ||||
Other comprehensive income (loss) | |||||||||||||||
Unrealized holding gain (loss) on available-for-sale securities, net | — | 4 | — | (1 | ) | ||||||||||
Comprehensive (loss) income | $ | (883 | ) | $ | (435 | ) | $ | 1,242 | $ | (712 | ) | ||||
Basic (loss) income per share of common stock from: | |||||||||||||||
Continuing operations | $ | (0.06 | ) | $ | (0.03 | ) | 0.08 | $ | (0.05 | ) | |||||
Discontinued operations | — | — | — | — | |||||||||||
Net (loss) income per basic share of common stock | $ | (0.06 | ) | $ | (0.03 | ) | 0.08 | $ | (0.05 | ) | |||||
Diluted (loss) income per share of common stock from: | |||||||||||||||
Continuing operations | $ | (0.06 | ) | $ | (0.03 | ) | $ | 0.08 | $ | (0.05 | ) | ||||
Discontinued operations | — | — | — | — | |||||||||||
Net (loss) income per diluted share of common stock | $ | (0.06 | ) | $ | (0.03 | ) | $ | 0.08 | $ | (0.05 | ) | ||||
Weighted average number of common shares and common share equivalents outstanding: | |||||||||||||||
Basic | 14,713 | 14,569 | 14,691 | 14,553 | |||||||||||
Diluted | 14,713 | 14,569 | 15,154 | 14,553 |
Six Months Ended | |||||||
June 30, | |||||||
2013 | 2012 | ||||||
Cash Flows From Operating Activities | |||||||
Net income (loss) | $ | 1,242 | $ | (711 | ) | ||
Adjustments to reconcile net income (loss) to net cash used in operating activities: | |||||||
Depreciation and amortization | 577 | 996 | |||||
Realignment accrual accretion | 71 | 71 | |||||
Stock-based compensation | 1,073 | 1,036 | |||||
Other changes in assets and liabilities: | |||||||
Decrease in accounts receivable | 4,584 | 727 | |||||
(Increase) decrease in unbilled costs | (5,599 | ) | 378 | ||||
Decrease (increase) in other current assets | 804 | (1,546 | ) | ||||
Decrease in other long-term assets | — | 1,018 | |||||
Decrease in accounts payable | (241 | ) | (572 | ) | |||
(Decrease) increase in unearned contract revenue | (2,532 | ) | 534 | ||||
Increase (decrease) in accrued salaries and bonus | 1,903 | (2,551 | ) | ||||
Decrease in other accrued expenses | (1,737 | ) | (5,079 | ) | |||
Decrease in long-term liabilities | (719 | ) | (1,142 | ) | |||
Net cash used in operating activities | (574 | ) | (6,841 | ) | |||
Cash Flows From Investing Activities | |||||||
Purchase of property and equipment | (956 | ) | (448 | ) | |||
Net cash used in investing activities | (956 | ) | (448 | ) | |||
Cash Flows From Financing Activities | |||||||
Cash paid for repurchase of restricted shares | (230 | ) | (110 | ) | |||
Net cash used in financing activities | (230 | ) | (110 | ) | |||
Net decrease in cash and cash equivalents | (1,760 | ) | (7,399 | ) | |||
Cash and cash equivalents – beginning | 52,783 | 64,337 | |||||
Cash and cash equivalents – ending | $ | 51,023 | $ | 56,938 |
1. | BASIS OF PRESENTATION |
2. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
Three Months Ended | Six Months Ended | ||||||||||
June 30, | June 30, | ||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||
Basic weighted average number of common shares | 14,713 | 14,569 | 14,691 | 14,553 | |||||||
Dilutive effect of stock-based awards | — | — | 463 | — | |||||||
Diluted weighted average number of common shares | 14,713 | 14,569 | 15,154 | 14,553 |
Three Months Ended | Six Months Ended | |||||||
June 30, | June 30, | |||||||
2013 | 2012 | 2013 | 2012 | |||||
Options | 50 | 84 | 50 | 84 | ||||
Stock-settled stock appreciation rights (SARs) | 901 | 582 | 711 | 582 | ||||
Restricted stock/units | 665 | 647 | 129 | 647 | ||||
Performance contingent SARs | 280 | 280 | 280 | 280 | ||||
1,896 | 1,593 | 1,170 | 1,593 |
3. | INVESTMENTS IN MARKETABLE SECURITIES |
Maturing | Maturing | ||||||||||||||||||||||
June 30, 2013 | within 1 year | after 1 year through 3 years | December 31, 2012 | within 1 year | after 1 year through 3 years | ||||||||||||||||||
Cash/money accounts | $ | 8 | $ | 8 | $ | — | $ | 76 | $ | 76 | $ | — | |||||||||||
US Treasury securities | 2,417 | 1,900 | 517 | 2,450 | 1,051 | 1,399 | |||||||||||||||||
Government agency securities | 827 | 827 | — | 1,270 | 881 | 389 | |||||||||||||||||
Total | $ | 3,252 | $ | 2,735 | $ | 517 | $ | 3,796 | $ | 2,008 | $ | 1,788 |
June 30, 2013 | December 31, 2012 | ||||||
Other current assets | $ | 2,228 | $ | 2,008 | |||
Other long-term assets | 1,024 | 1,788 | |||||
Total | $ | 3,252 | $ | 3,796 |
4. | GOODWILL AND OTHER INTANGIBLE ASSETS |
5. | FACILITIES REALIGNMENT |
Sales Services | Marketing Services | Discontinued Operations | Total | ||||||||||||
Balance as of December 31, 2012 | $ | 2,027 | $ | 637 | $ | 615 | $ | 3,279 | |||||||
Accretion | 56 | — | 15 | 71 | |||||||||||
Adjustments | — | — | — | — | |||||||||||
Payments | (669 | ) | (103 | ) | (153 | ) | (925 | ) | |||||||
Balance as of June 30, 2013 | $ | 1,414 | $ | 534 | $ | 477 | $ | 2,425 |
6. | FAIR VALUE MEASUREMENTS |
Level 1: | Valuations for assets and liabilities traded in active markets from readily available pricing sources for market transactions involving identical assets or liabilities. |
Level 2: | Valuations for assets and liabilities traded in less active dealer or broker markets. Valuations are obtained from third-party pricing services for identical or similar assets or liabilities. |
Level 3: | Valuations incorporate certain assumptions and projections in determining the fair value assigned to such assets or liabilities. |
As of June 30, 2013 | Fair Value Measurements | ||||||||||||||||||
Carrying | Fair | As of June 30, 2013 | |||||||||||||||||
Amount | Value | Level 1 | Level 2 | Level 3 | |||||||||||||||
Assets: | |||||||||||||||||||
Cash and cash equivalents: | |||||||||||||||||||
Cash | $ | 9,194 | $ | 9,194 | $ | 9,194 | $ | — | $ | — | |||||||||
Money Market Funds | 41,829 | 41,829 | 41,829 | — | — | ||||||||||||||
Total | $ | 51,023 | $ | 51,023 | $ | 51,023 | $ | — | $ | — | |||||||||
Marketable securities: | |||||||||||||||||||
Money Market Funds | $ | 48 | $ | 48 | $ | 48 | $ | — | $ | — | |||||||||
Mutual Funds | 44 | 44 | 44 | — | — | ||||||||||||||
U.S. Treasury securities | 2,417 | 2,417 | 2,417 | — | — | ||||||||||||||
Government agency securities | 827 | 827 | 827 | — | — | ||||||||||||||
Total | $ | 3,336 | $ | 3,336 | $ | 3,336 | $ | — | $ | — |
7. | COMMITMENTS AND CONTINGENCIES |
8. | ACCRUED EXPENSES AND LONG-TERM LIABILTIES |
June 30, 2013 | December 31, 2012 | ||||||
Accrued pass-through costs | $ | 2,762 | $ | 3,729 | |||
Accrued reorganization expense | 1,085 | 1,495 | |||||
Self insurance accruals | 967 | 900 | |||||
Indemnification liability | 875 | 875 | |||||
All others | 4,401 | 4,828 | |||||
$ | 10,090 | $ | 11,827 |
June 30, 2013 | December 31, 2012 | ||||||
Rent payable | $ | 1,255 | $ | 1,533 | |||
Uncertain tax positions | 3,043 | 2,967 | |||||
Restructuring | 1,340 | 1,785 | |||||
Other | 141 | 142 | |||||
$ | 5,779 | $ | 6,427 |
9. | STOCK-BASED COMPENSATION |
Six Months Ended | ||||
June 30, 2013 | June 30, 2012 | |||
Risk-free interest rate | 0.33% | 0.31% | ||
Expected life (in years) | 3.5 | 3.5 | ||
Expected volatility | 49.80% | 57.62% | ||
Dividend yield | —% | —% |
10. | INCOME TAXES |
Three Months Ended | Six Months Ended | ||||||||||||||
June 30, | June 30, | ||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||
Provision for income tax | $ | 64 | $ | 63 | $ | 128 | $ | 145 | |||||||
Effective income tax rate | (7.3 | )% | (19.0 | )% | 9.3 | % | (26.3 | )% |
11. | SEGMENT INFORMATION |
Sales Services | Marketing Services | Product Commercialization Services | Consolidated | ||||||||||||
Three months ended June 30, 2013: | |||||||||||||||
Revenue | $ | 32,294 | $ | 1,644 | $ | 3,307 | $ | 37,245 | |||||||
Operating (loss) income | $ | (1,017 | ) | $ | (518 | ) | $ | 688 | $ | (847 | ) | ||||
Capital expenditures | $ | 86 | $ | 425 | $ | — | $ | 511 | |||||||
Depreciation expense | $ | 216 | $ | 48 | $ | 25 | $ | 289 | |||||||
Three months ended June 30, 2012: | |||||||||||||||
Revenue | $ | 20,149 | $ | 2,802 | $ | 4,858 | $ | 27,809 | |||||||
Operating (loss) income | $ | (560 | ) | $ | (744 | ) | $ | 988 | $ | (316 | ) | ||||
Capital expenditures | $ | 435 | $ | 3 | $ | — | $ | 438 | |||||||
Depreciation expense | $ | 171 | $ | 67 | $ | 30 | $ | 268 | |||||||
Six months ended June 30, 2013: | |||||||||||||||
Revenue | $ | 70,519 | $ | 3,185 | $ | 6,464 | $ | 80,168 | |||||||
Operating income (loss) | $ | 1,347 | $ | (1,201 | ) | $ | 1,260 | $ | 1,406 | ||||||
Capital expenditures | $ | 255 | $ | 701 | $ | — | $ | 956 | |||||||
Depreciation expense | $ | 450 | $ | 99 | $ | 28 | $ | 577 | |||||||
Six months ended June 30, 2012: | |||||||||||||||
Revenue | $ | 43,518 | $ | 5,865 | $ | 10,103 | $ | 59,486 | |||||||
Operating (loss) income | $ | (1,130 | ) | $ | (1,211 | ) | $ | 1,804 | $ | (537 | ) | ||||
Capital expenditures | $ | 440 | $ | 8 | $ | — | $ | 448 | |||||||
Depreciation expense | $ | 373 | $ | 135 | $ | 36 | $ | 544 |
12. | DISCONTINUED OPERATIONS |
Three Months Ended | Six Months Ended | ||||||||||||||
June 30, | June 30, | ||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||
Revenue, net | $ | — | $ | — | $ | — | $ | — | |||||||
Income (loss) from discontinued operations, before income tax | 53 | (44 | ) | — | (11 | ) | |||||||||
Provision for income tax | 1 | 1 | 2 | 3 | |||||||||||
Income (loss) from discontinued operations, net of tax | $ | 52 | $ | (45 | ) | $ | (2 | ) | $ | (14 | ) |
June 30, 2013 | December 31, 2012 | ||||||
Current assets | $ | 16 | $ | 14 | |||
Non-current assets | 150 | 150 | |||||
Total assets | $ | 166 | $ | 164 | |||
Current liabilities | $ | 412 | $ | 368 | |||
Non-current liabilities | 810 | 1,006 | |||||
Total liabilities | $ | 1,222 | $ | 1,374 |
• | Changes in outsourcing trends or a reduction in promotional, marketing and sales expenditures in the pharmaceutical, biotechnology and healthcare industries; |
• | Our customer concentration risk in light of continued consolidation within the pharmaceutical industry and our current business development opportunities; |
• | Early termination of a significant services contract, the loss of one or more of our significant customers or a material reduction in service revenues from such customers; |
• | Our ability to obtain additional funds in order to implement our business model and strategy; |
• | Our ability to successfully identify, complete and integrate any future acquisitions and the effects of any such acquisitions on our ongoing business; |
• | Our ability to meet performance goals in incentive-based arrangements with customers; |
• | Our ability to successfully negotiate contracts with reasonable margins and favorable payment terms; |
• | Competition in our industry; |
• | Our ability to attract and retain qualified sales representatives and other key employees and management personnel; |
• | Product liability claims against us; |
• | Failure of third-party service providers to perform their obligations to us; |
• | Volatility of our stock price and fluctuations in our quarterly and annual revenues and earnings; |
• | Failure of, or significant interruption to, the operation of our information technology and communication systems; and |
• | The results of any future impairment testing for goodwill and other intangible assets. |
• | Sales Services, which is comprised of the following business units: |
• | Dedicated Sales Teams; |
• | Established Relationship Teams (ERT) (formerly known as Shared Sales Teams); and |
• | EngageCE. |
• | Marketing Services, which is comprised of the following business units: |
• | Group DCA; and |
• | Voice. |
• | Product Commercialization Services (PC Services) which is comprised of the following business unit: |
• | Interpace BioPharma. |
Three Months Ended | Six Months Ended | ||||||||||
June 30, | June 30, | ||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||
Revenue, net | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | |||
Cost of services | 81.6 | % | 76.4 | % | 80.9 | % | 76.6 | % | |||
Gross profit | 18.4 | % | 23.6 | % | 19.1 | % | 23.4 | % | |||
Compensation expense | 13.2 | % | 14.6 | % | 11.3 | % | 14.5 | % | |||
Other selling, general and administrative expenses | 7.5 | % | 10.1 | % | 6.0 | % | 9.8 | % | |||
Total operating expenses | 20.7 | % | 24.8 | % | 17.4 | % | 24.3 | % | |||
Operating (loss) income | (2.3 | )% | (1.2 | )% | 1.7 | % | (0.9 | )% | |||
Other expense, net | (0.1 | )% | (0.1 | )% | — | % | — | % | |||
(Loss) income from continuing operations before income tax | (2.3 | )% | (1.2 | )% | 1.7 | % | (0.9 | )% | |||
Provision for income tax | 0.2 | % | 0.2 | % | 0.2 | % | 0.2 | % | |||
(Loss) income from continuing operations | (2.5 | )% | (1.4 | )% | 1.6 | % | (1.2 | )% |
Revenue, net (in thousands) | Three Months Ended | |||||||||||||
June 30, | ||||||||||||||
2013 | 2012 | Change ($) | Change (%) | |||||||||||
Sales Services | $ | 32,294 | $ | 20,149 | $ | 12,145 | 60.3 | % | ||||||
Marketing Services | 1,644 | 2,802 | (1,158 | ) | (41.3 | )% | ||||||||
PC Services | 3,307 | 4,858 | (1,551 | ) | (31.9 | )% | ||||||||
Total | $ | 37,245 | $ | 27,809 | $ | 9,436 | 33.9 | % |
Cost of services (in thousands) | Three Months Ended | |||||||||||||
June 30, | ||||||||||||||
2013 | 2012 | Change ($) | Change (%) | |||||||||||
Sales Services | $ | 27,042 | $ | 16,121 | $ | 10,921 | 67.7 | % | ||||||
Marketing Services | 1,006 | 1,767 | (761 | ) | (43.1 | )% | ||||||||
PC Services | 2,348 | 3,351 | (1,003 | ) | (29.9 | )% | ||||||||
Total | $ | 30,396 | $ | 21,239 | $ | 9,157 | 43.1 | % |
Gross profit (in thousands) | ||||||||||||||||||||||||||||
Three Months Ended | Sales | % of | Marketing | % of | PC | % of | % of | |||||||||||||||||||||
June 30, | Services | Sales | Services | Sales | Services | Sales | Total | Sales | ||||||||||||||||||||
2013 | $ | 5,252 | 16.3 | % | $ | 638 | 38.8 | % | $ | 959 | 29.0 | % | $ | 6,849 | 18.4 | % | ||||||||||||
2012 | 4,028 | 20.0 | % | 1,035 | 36.9 | % | 1,507 | 31.0 | % | 6,570 | 23.6 | % | ||||||||||||||||
Change | $ | 1,224 | $ | (397 | ) | $ | (548 | ) | $ | 279 |
Compensation expense (in thousands) | ||||||||||||||||||||||||||||
Three Months Ended | Sales | % of | Marketing | % of | PC | % of | % of | |||||||||||||||||||||
June 30, | Services | Sales | Services | Sales | Services | Sales | Total | Sales | ||||||||||||||||||||
2013 | $ | 4,105 | 12.7 | % | $ | 658 | 40.0 | % | $ | 151 | 4.6 | % | $ | 4,914 | 13.2 | % | ||||||||||||
2012 | 3,018 | 15.0 | % | 763 | 27.2 | % | 288 | 5.9 | % | 4,069 | 14.6 | % | ||||||||||||||||
Change | $ | 1,087 | $ | (105 | ) | $ | (137 | ) | $ | 845 |
Other selling, general and administrative expenses (in thousands) | ||||||||||||||||||||||||||||
Three Months Ended | Sales | % of | Marketing | % of | PC | % of | % of | |||||||||||||||||||||
June 30, | Services | Sales | Services | Sales | Services | Sales | Total | Sales | ||||||||||||||||||||
2013 | $ | 2,164 | 6.7 | % | $ | 498 | 30.3 | % | $ | 120 | 3.6 | % | $ | 2,782 | 7.5 | % | ||||||||||||
2012 | 1,570 | 7.8 | % | 1,016 | 36.3 | % | 231 | 4.8 | % | 2,817 | 10.1 | % | ||||||||||||||||
Change | $ | 594 | $ | (518 | ) | $ | (111 | ) | $ | (35 | ) |
Revenue, net (in thousands) | Six Months Ended | |||||||||||||
June 30, | ||||||||||||||
2013 | 2012 | Change ($) | Change (%) | |||||||||||
Sales Services | $ | 70,519 | $ | 43,518 | $ | 27,001 | 62.0 | % | ||||||
Marketing Services | 3,185 | 5,865 | (2,680 | ) | (45.7 | )% | ||||||||
PC Services | 6,464 | 10,103 | (3,639 | ) | (36.0 | )% | ||||||||
Total | $ | 80,168 | $ | 59,486 | $ | 20,682 | 34.8 | % |
Cost of services (in thousands) | Six Months Ended | |||||||||||||
June 30, | ||||||||||||||
2013 | 2012 | Change ($) | Change (%) | |||||||||||
Sales Services | $ | 57,948 | $ | 34,537 | $ | 23,411 | 67.8 | % | ||||||
Marketing Services | 2,163 | 3,595 | (1,432 | ) | (39.8 | )% | ||||||||
PC Services | 4,735 | 7,418 | (2,683 | ) | (36.2 | )% | ||||||||
Total | $ | 64,846 | $ | 45,550 | $ | 19,296 | 42.4 | % |
Gross profit (in thousands) | ||||||||||||||||||||||||||||
Six Months Ended | Sales | % of | Marketing | % of | PC | % of | % of | |||||||||||||||||||||
June 30, | Services | Sales | Services | Sales | Services | Sales | Total | Sales | ||||||||||||||||||||
2013 | $ | 12,571 | 17.8 | % | $ | 1,022 | 32.1 | % | $ | 1,729 | 26.7 | % | $ | 15,322 | 19.1 | % | ||||||||||||
2012 | 8,981 | 20.6 | % | 2,270 | 38.7 | % | 2,685 | 26.6 | % | 13,936 | 23.4 | % | ||||||||||||||||
Change | $ | 3,590 | $ | (1,248 | ) | $ | (956 | ) | $ | 1,386 |
Compensation expense (in thousands) | ||||||||||||||||||||||||||||
Six Months Ended | Sales | % of | Marketing | % of | PC | % of | % of | |||||||||||||||||||||
June 30, | Services | Sales | Services | Sales | Services | Sales | Total | Sales | ||||||||||||||||||||
2013 | $ | 7,494 | 10.6 | % | $ | 1,310 | 41.1 | % | $ | 265 | 4.1 | % | $ | 9,069 | 11.3 | % | ||||||||||||
2012 | 6,620 | 15.2 | % | 1,554 | 26.5 | % | 477 | 4.7 | % | 8,651 | 14.5 | % | ||||||||||||||||
Change | $ | 874 | $ | (244 | ) | $ | (212 | ) | $ | 418 |
Other selling, general and administrative expenses (in thousands) | ||||||||||||||||||||||||||||
Six Months Ended | Sales | % of | Marketing | % of | PC | % of | % of | |||||||||||||||||||||
June 30, | Services | Sales | Services | Sales | Services | Sales | Total | Sales | ||||||||||||||||||||
2013 | $ | 3,730 | 5.3 | % | $ | 913 | 28.7 | % | $ | 204 | 3.2 | % | $ | 4,847 | 6.0 | % | ||||||||||||
2012 | 3,491 | 8.0 | % | 1,927 | 32.9 | % | 404 | 4.0 | % | 5,822 | 9.8 | % | ||||||||||||||||
Change | $ | 239 | $ | (1,014 | ) | $ | (200 | ) | $ | (975 | ) |
Exhibit No. | Description | |
31.1 | Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith. | |
31.2 | Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith. | |
32.1 | Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, filed herewith. | |
32.2 | Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, filed herewith. | |
101 | The following financial information from this Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2013 formatted in XBRL (Extensible Business Reporting Language) and furnished electronically herewith: (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Operations; (iii) the Condensed Consolidated Statements of Cash Flows; and (iv) the Notes to Condensed Consolidated Financial Statements. |
Date: | August 5, 2013 | PDI, Inc. | |
(Registrant) | |||
/s/ Nancy S. Lurker | |||
Nancy S. Lurker | |||
Chief Executive Officer | |||
/s/ Jeffrey Smith | |||
Jeffrey Smith | |||
Chief Financial Officer |
1. | I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 of PDI, Inc. (the “registrant”); |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c. | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d. | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
Date: | August 5, 2013 | /s/ Nancy S. Lurker |
Chief Executive Officer | ||
(Principal Executive Officer) | ||
1. | I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 of PDI, Inc. (the “registrant”); |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c. | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d. | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
Date: | August 5, 2013 | /s/ Jeffrey E. Smith |
Chief Financial Officer | ||
(Principal Financial Officer) | ||
(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: | August 5, 2013 | /s/ Nancy S. Lurker |
Chief Executive Officer | ||
(Principal Executive Officer) |
(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: | August 5, 2013 | /s/ Jeffrey E. Smith |
Chief Financial Officer | ||
(Principal Financial Officer) | ||
Discontinued Operations
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discontinued Operations and Disposal Groups [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discontinued Operations [Text Block] | DISCONTINUED OPERATIONS On December 29, 2011, we entered into an agreement to sell certain assets of our Pharmakon business unit to Informed in exchange for potential future royalty payments and a 1% ownership interest in Informed. The consolidated statement of operations reflects the presentation of Pharmakon as a discontinued operation in all periods presented. On July 19, 2010, the Board approved closing the TVG business unit. The Company completed the closure of the TVG operations during the quarter ended September 30, 2010, including the completion of all active customer contracts. The financial statements reflect the presentation of TVG as a discontinued operation in all periods presented. The table below presents the significant components of Pharmakon's and TVG’s results included in Income (loss) from Discontinued Operations in the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income for the three- and six-month periods ended June 30, 2013 and 2012.
The major classes of assets and liabilities included in the Condensed Consolidated Balance Sheets for TVG and Pharmakon as of June 30, 2013 and December 31, 2012 are as follows:
|
Facilities Realignment
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FACILITIES REALIGNMENT [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Facilities Realignment [Text Block] | FACILITIES REALIGNMENT The following table presents a rollforward of the Company’s restructuring reserve from December 31, 2012 to June 30, 2013, of which approximately $1.1 million is included in other accrued expenses and $1.3 million is included in long-term liabilities as of June 30, 2013. The Company recognizes accretion expense in Other expense, net in the Condensed Consolidated Statement of Operations and Comprehensive (Loss) Income.
|
Stock-Based Compensation (Tables)
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
|||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |||||||||||||||||||||||||||||||||||||||||
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] |
|
Summary of Significant Accounting Policies (Policies)
|
6 Months Ended |
---|---|
Jun. 30, 2013
|
|
Accounting Policies [Abstract] | |
Accounting Estimates [Policy Text Block] | Accounting Estimates The preparation of the interim financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities reported and disclosure of contingent assets and liabilities at the date of the interim financial statements and the reported amounts of revenues and expenses during the reporting period. Management's estimates are based on historical experience, facts and circumstances available at the time, and various other assumptions that are believed to be reasonable under the circumstances. Significant estimates include incentives earned or penalties incurred on contracts, best estimate of selling price in multiple element arrangements, valuation allowances related to deferred income taxes, self-insurance loss accruals, allowances for doubtful accounts and notes, income tax accruals, acquisition accounting, asset impairments and facilities realignment accruals. The Company periodically reviews these matters and reflects changes in estimates as appropriate. Actual results could materially differ from those estimates. |
Goodwill and Other Intangible Assets [Policy Text Block] | Goodwill and Other Intangible Assets The Company allocates the cost of acquired companies to the identifiable tangible and intangible assets acquired and liabilities assumed, with the remaining amount classified as goodwill. Since the entities the Company has acquired do not have significant tangible assets, a significant portion of the purchase price has been allocated to intangible assets and goodwill. The identification and valuation of these intangible assets and the determination of the estimated useful lives at the time of acquisition, as well as the completion of impairment tests require significant management judgments and estimates. These estimates are made based on, among other factors, consultations with an accredited independent valuation consultant, reviews of projected future operating results and business plans, economic projections, anticipated highest and best use of future cash flows and the market participant cost of capital. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of goodwill and other intangible assets, and potentially result in a different impact to the Company's results of operations. Further, changes in business strategy and/or market conditions may significantly impact these judgments thereby impacting the fair value of these assets, which could result in an impairment of the goodwill. The Company tests goodwill and indefinite lived intangible assets for impairment at least annually (as of December 31) and whenever events or circumstances change that indicate impairment may have occurred. A significant amount of judgment is involved in determining if an indicator of impairment has occurred. Such indicators may include, among others: a significant decline in expected future cash flows; a sustained, significant decline in stock price and market capitalization; a significant adverse change in legal factors or in the business climate of the pharmaceutical industry; unanticipated competition; and slower growth rates. Any adverse change in these factors could have a significant impact on the recoverability of goodwill and our consolidated financial results. At June 30, 2013, no indicators of impairment were identified. |
Cost of Services - Initial Direct Program Costs [Policy Text Block] | Cost of Services - Initial Direct Program Costs Initial direct program costs are the costs associated with initiating a product detailing program, such as recruiting and hiring and certain other direct incremental costs, excluding pass through costs that are billed to customers. Through March 31, 2012, the Company expensed these initial direct program costs as incurred, as these amounts were not material to the operating results of the Company. As a result of the Company's recent contract signings and plans to enter into larger contracts in the future, requiring more material initial direct program costs, commencing April 1, 2012, the Company changed its policy for the recognition of such initial direct program costs. These costs are now being deferred and amortized to expense in proportion to the revenue recognized as driven by the terms of the contract. This change in accounting was not applied retrospectively because the effect on prior periods was immaterial. At June 30, 2013 and December 31, 2012, the Company deferred $2.2 million and $1.8 million of initial direct program costs, respectively. For the three month and six month periods ended June 30, 2013, the Company amortized $0.2 million and $0.5 million into expense, respectively. For the three month period ended June 30, 2012, $0.1 million of initial direct program costs were amortized to expense. |
Stock-Based Compensation (Details) (USD $)
In Thousands, except Share data, unless otherwise specified |
3 Months Ended | 6 Months Ended | 0 Months Ended | |||
---|---|---|---|---|---|---|
Jun. 30, 2013
|
Jun. 30, 2012
|
Jun. 30, 2013
|
Jun. 30, 2012
|
Apr. 04, 2013
Management [Member]
Restricted Stock [Member]
|
Apr. 04, 2013
Management [Member]
Stock Appreciation Rights (SARs) [Member]
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 5.44 | $ 1.97 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | 143,695 | 396,760 | ||||
Risk-free Interest Rate | 0.33% | 0.31% | ||||
Expected life (in years) | 3 years 6 months | 3 years 6 months | ||||
Expected volatility | 49.80% | 57.62% | ||||
Dividend Yield | 0.00% | 0.00% | ||||
Stock-based Compensation Expense | $ 700 | $ 600 | $ 1,073 | $ 1,036 |
Discontinued Operations (Tables)
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discontinued Operations and Disposal Groups [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block] |
|
Segment Information (Tables)
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Segment Reporting Information, by Segment [Table Text Block] |
|
Segment Information (Details) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2013
|
Jun. 30, 2012
|
Jun. 30, 2013
|
Jun. 30, 2012
|
|
Segment Reporting Information [Line Items] | ||||
Revenues | $ 37,245 | $ 27,809 | $ 80,168 | $ 59,486 |
Operating (loss) income | (847) | (316) | 1,406 | (537) |
Capital expenditures | 511 | 438 | 956 | 448 |
Depreciation expense | 289 | 268 | 577 | 544 |
Sales Services [Member]
|
||||
Segment Reporting Information [Line Items] | ||||
Revenues | 32,294 | 20,149 | 70,519 | 43,518 |
Operating (loss) income | (1,017) | (560) | 1,347 | (1,130) |
Capital expenditures | 86 | 435 | 255 | 440 |
Depreciation expense | 216 | 171 | 450 | 373 |
Marketing Services [Member]
|
||||
Segment Reporting Information [Line Items] | ||||
Revenues | 1,644 | 2,802 | 3,185 | 5,865 |
Operating (loss) income | (518) | (744) | (1,201) | (1,211) |
Capital expenditures | 425 | 3 | 701 | 8 |
Depreciation expense | 48 | 67 | 99 | 135 |
Product Commercialization Services [Member]
|
||||
Segment Reporting Information [Line Items] | ||||
Revenues | 3,307 | 4,858 | 6,464 | 10,103 |
Operating (loss) income | 688 | 988 | 1,260 | 1,804 |
Capital expenditures | 0 | 0 | 0 | 0 |
Depreciation expense | $ 25 | $ 30 | $ 28 | $ 36 |
Summary of Significant Accounting Policies Contract costs (Details) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | 6 Months Ended | 12 Months Ended | |
---|---|---|---|---|
Jun. 30, 2013
|
Jun. 30, 2012
|
Jun. 30, 2013
|
Dec. 31, 2012
|
|
Contract Start-up Costs [Abstract] | ||||
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] | 2.2 | 1.8 | ||
Amortization | $ 200 | $ 100 | $ 500 |
Income Taxes (Tables)
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] | The following table summarizes income tax expense on (loss) income from continuing operations and the effective tax rate for the three- and six-month periods ended June 30, 2013 and 2012:
|
Basis of Presentation
|
6 Months Ended |
---|---|
Jun. 30, 2013
|
|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation [Text Block] | BASIS OF PRESENTATION The accompanying unaudited interim condensed consolidated financial statements and related notes (the interim financial statements) should be read in conjunction with the consolidated financial statements of PDI, Inc. and its subsidiaries (the Company or PDI) and related notes as included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012 as filed with the Securities and Exchange Commission (SEC) on March 14, 2013. The interim financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States (GAAP) for interim financial reporting and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The interim financial statements include all normal recurring adjustments that, in the judgment of management, are necessary for a fair presentation of such interim financial statements. All significant intercompany balances and transactions have been eliminated in consolidation. Operating results for the three-month period ended June 30, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. |
Investments in Marketable Securities
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Marketable Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments in Marketable Securities [Text Block] | INVESTMENTS IN MARKETABLE SECURITIES Available-for-sale securities are carried at fair value with the unrealized holding gains or losses, net of tax, included as a component of accumulated other comprehensive income (loss) in stockholders’ equity. Realized gains and losses on available-for-sale securities are computed based upon specific identification and included in other income (expense), net in the consolidated statement of operations. Declines in value judged to be other-than-temporary on available-for-sale securities are recorded in other income (expense), net in the consolidated statement of operations and the cost basis of the security is reduced. The fair values for marketable equity securities are based on quoted market prices. Held-to-maturity investments are stated at amortized cost which approximates fair value. Interest income is accrued as earned. Realized gains and losses on held-to-maturity investments are computed based upon specific identification and included in other income (expense), net in the condensed consolidated statement of operations. The Company does not have any investments classified as trading. Available-for-sale securities consist of assets in a rabbi trust associated with the Company’s deferred compensation plan. As of June 30, 2013 and December 31, 2012, the carrying value of available-for-sale securities was approximately $92,000 and $92,000, respectively, and is included in short-term investments. Available-for-sale securities at June 30, 2013 and December 31, 2012 consisted of $44,000 and $44,000, respectively, in mutual funds, and approximately $48,000 and $48,000, respectively, in money market accounts. The Company’s other marketable securities consist of investment grade debt instruments such as obligations of U.S. Treasury and U.S. Federal Government agencies. These investments are categorized as held-to-maturity since the Company’s management has the ability and intent to hold these securities to maturity. The Company’s held-to-maturity investments are carried at amortized cost which approximates fair value and are maintained in separate accounts to support the Company’s letters of credit. The Company had standby letters of credit of approximately $2.2 million as of June 30, 2013 and $2.6 million at December 31, 2012, as collateral for its existing insurance policies and facility leases. At June 30, 2013 and December 31, 2012, held-to-maturity investments included the following:
At June 30, 2013 and December 31, 2012, held-to-maturity investments were recorded in the following accounts:
|
Fair Value Measurements
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Measurements [Text Block] | FAIR VALUE MEASUREMENTS The Company's financial assets and liabilities reflected at fair value in the consolidated financial statements include: cash and cash equivalents; short-term investments; accounts receivable; other current assets; accounts payable; and contingent consideration. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value, the Company uses various methods including market, income and cost approaches. Based on these approaches, the Company often utilizes certain assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and/or the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market-corroborated, or generally unobservable inputs. The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. Based upon observable inputs used in the valuation techniques, the Company is required to provide information according to the fair value hierarchy. The fair value hierarchy ranks the quality and reliability of the information used to determine fair values into three broad levels as follows:
In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability. The valuation methodologies used for the Company's financial instruments measured on a recurring basis at fair value, including the general classification of such instruments pursuant to the valuation hierarchy, is set forth in the table below.
The fair value of cash and cash equivalents and marketable securities is valued using market prices in active markets (level 1). As of June 30, 2013, the Company did not have any marketable securities in less active markets (level 2) or (level 3). The Company considers carrying amounts of accounts receivable, accounts payable and accrued expenses to approximate fair value due to the short-term nature of these financial instruments. There is no fair value ascribed to the letters of credit as management does not expect any material losses to result from these instruments because performance is not expected to be required. |
Goodwill and Other Intangible Assets
|
6 Months Ended |
---|---|
Jun. 30, 2013
|
|
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Other Intangible Assets [Text Block] | GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill recorded as of June 30, 2013 is attributable to the 2010 acquisition of Group DCA. As of June 30, 2013 and December 31, 2012, the carrying amount of goodwill for Group DCA was $2.5 million. There is no amortization expense in 2013 as the Company's intangible assets were written-off in the fourth quarter of 2012. Amortization expense was $0.2 million for the three-month period ended June 30, 2012 and $0.5 million for the six-month period ended June 30, 2012. |
Discontinued Operations (Details) (USD $)
|
3 Months Ended | 6 Months Ended | |||
---|---|---|---|---|---|
Jun. 30, 2013
|
Jun. 30, 2012
|
Jun. 30, 2013
|
Jun. 30, 2012
|
Dec. 31, 2012
|
|
Discontinued Operations and Disposal Groups [Abstract] | |||||
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | 1.00% | ||||
Revenue, net | $ 0 | $ 0 | $ 0 | $ 0 | |
(Loss) income from discontinued operations, before income tax | 53,000 | (44,000) | 0 | (11,000) | |
Provision (benefit) for income tax | 1,000 | 1,000 | 2,000 | 3,000 | |
Income (loss) from discontinued operations, net of tax | 52,000 | (45,000) | (2,000) | (14,000) | |
Current assets | 16,000 | 16,000 | 14,000 | ||
Non-current assets | 150,000 | 150,000 | 150,000 | ||
Total assets | 166,000 | 166,000 | 164,000 | ||
Current liabilities | 412,000 | 412,000 | 368,000 | ||
Non-current liabilities | 810,000 | 810,000 | 1,006,000 | ||
Total liabilities | $ 1,222,000 | $ 1,222,000 | $ 1,374,000 |
Basis of Presentation (Details)
|
Dec. 31, 2012
|
---|---|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | 1.00% |
Accrued Expenses and Long-Term Liabilities (Details) (USD $)
In Thousands, unless otherwise specified |
Jun. 30, 2013
|
Dec. 31, 2012
|
---|---|---|
Other Liabilities Disclosure [Abstract] | ||
Other Liabilities | $ 2,762 | $ 3,729 |
Accrued reorganization expense | 1,085 | 1,495 |
Rent Payable | 1,255 | 1,533 |
Uncertain Tax Positions | 3,043 | 2,967 |
Restructuring | 1,340 | 1,785 |
Other | 141 | 142 |
Total Long-Term Liabilities | 5,779 | 6,427 |
Self insurance accruals | 967 | 900 |
Indemnification liability | 875 | 875 |
All others | 4,401 | 4,828 |
Other accrued expenses | $ 10,090 | $ 11,827 |